Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. Its lead product candidate is QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania.

Palvella Therapeutics, Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Palvella Therapeutics (PVLA) and Lifecore Biomedical...

Analysts Are Bullish on Top Healthcare Stocks: Palvella Therapeutics (PVLA), Lifecore Biomedical (LFCR)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pfizer (PFE), Crispr Therapeutics AG (CRSP) and Palv...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Palvella Therapeutics, Inc. (($PVLA)) has held its Q2 earnings call. Read on for the main highlights of the call. Palvella Therapeutics’ latest ear...

Palvella Therapeutics Charts Clear Path From Data To Launch

In a report released today, Ritu Baral from TD Cowen reiterated a Buy rating on Palvella Therapeutics, with a price target of $267.00. According to...

Palvella Therapeutics (PVLA) Receives a Rating Update from a Top Analyst

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Palvella Therapeutics (PVLA), Neogen (NEOG) and ACADIA Pharmaceut...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Palvella Therapeutics (PVLA), Neogen (NEOG) and ACADIA Pharmaceuticals (ACAD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Palvella Therapeutics (PVLA) and Armata Pharmaceutic...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PVLA	$157.77	+1.83%	182.30K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PVLA	$157.77	+1.8%	182.30K
3
4
5
6

PVLA

PVLA

Get Palvella Therapeutics, Inc. Data in Excel

Get Palvella Therapeutics, Inc. Data in Excel